DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Share Price

Certificat

DE000ME7TXP4

Market Closed - Bid/Ask 07:52:42 05/06/2024 pm IST After market 12:12:56 am
169.5 EUR +0.14% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. 169.5 -0.01%
Current month+0.24%
1 month-0.28%
Date Price Change
05/24/05 169.5 +0.14%
04/24/04 169.3 +0.21%
03/24/03 168.9 +0.03%
31/24/31 168.9 +0.06%
30/24/30 168.8 -0.09%

Delayed Quote Börse Stuttgart

Last update June 05, 2024 at 07:52 pm IST

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME7TXP
ISINDE000ME7TXP4
Date issued 29/01/2024
Maturity 20/12/2024 (198 Days)
Parity 1 : 1
Emission price 168.2
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 170.6
Lowest since issue 164.5
Spread 0.08
Spread %0.05%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
238.5 USD
Average target price
278.7 USD
Spread / Average Target
+16.85%
Consensus